Institutional investors purchased a net $757.9 thousand shares of CVM during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 4.85% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CIBC WORLD MARKETS, INC. Bought 10.0 Thousand shares of CEL-SCI Corp
NORTH AMERICAN MANAGEMENT CORP. Bought 10.0 Thousand shares of CEL-SCI Corp
CREATIVE PLANNING, INC. Sold 5.1 Thousand shares of CEL-SCI Corp